EXploring Immune-related Adverse Events of Immune checkpoinT Inhibitors Using VigiBase, the WHO Pharmacovigilance Database

Clinical trial NCT05934214 · COMPLETED

Trial details

NCT number: NCT05934214
Sponsor: Groupe Hospitalier Pitie-Salpetriere
Status: COMPLETED
Study type: OBSERVATIONAL

Cancer Immune-related Adverse Event Immune Checkpoint Inhibitor-Related Myocarditis

Start date: 2023-01-01
Primary completion: 2023-12-31
Enrollment: 141630

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.